Premium
Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression
Author(s) -
Wera Stefaan,
Belayew Alexandra,
Martial Joseph A.
Publication year - 1995
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(94)01416-x
Subject(s) - prolactin , transcription (linguistics) , gene expression , gene , endocrinology , transcription factor , medicine , mechanism of action , chemistry , biology , hormone , biochemistry , in vitro , linguistics , philosophy
In this work we demonstrate that transcription of the human prolactin gene is inhibited by the immunosuppressants FK506 (IC 50 = 25 NM), cyclosporin A (IC 50 = 190 NM) and rapamycin (IC 50 = 25 NM). Whereas the effect of FK506 and cyclosporin A is specific for prolactin gene transcription, rapamycin has a more general effect on transcription and/or translation in pituitary cells. In view of recent work demonstrating the immunoactivating role of prolactin, these results suggest that inhibition of prolactin gene expression in the pituitary may contribute to the mechanism of action of immunosuppressants.